Health Care / Hospitals
Releases published in the last 30 days. 
Page 3 of 3
- Johnson & Johnson late-breaking results show nipocalimab significantly reduced systemic lupus erythematosus (SLE) disease activity in a Phase 2 study
- 6/3/2026 10:03:16 AM
- · Nipocalimab – the first and only neonatal Fc receptor (FcRn) blocker to be studied in systemic lupus erythematosus – is designed to target and reduce pathogenic immunoglobulin G (IgG) autoantibodies associated with this disease while preserving immune function · Results demonstrated significant reduction of systemic lupus erythematosus disease activity which continued …
- “9 Simple Solutions to Achieve Health Equity” Will Be Available as a FREE Download for Five Days on Amazon (ending 06/05/2026)
- 6/3/2026 6:00:00 AM
- Best Seller Publishing is pleased to announce a limited-time FREE eBook for “9 Simple Solutions to Achieve Health Equity: A Guide for Healthcare Professionals and Patients” by Mauvareen Beverley, M.D., a nationally recognized expert in patient engagement and health equity.
- FDA Issues Draft Guidance to Help Accelerate Cell and Gene Therapies for Patients
- 6/2/2026 10:54:17 AM
- The U.S. Food and Drug Administration (FDA) today issued draft guidance to help developers bring promising gene therapies to patients more efficiently by making greater use of existing scientific and regulatory knowledge.
- Study Links Cannabis and Tobacco Co-Use to Lower Brain Performance in At-Risk Adolescents
- 6/2/2026 10:50:35 AM
- New research shows that among people at clinical high risk for psychosis, cannabis and tobacco co-use was associated with lower cognitive performance compared to healthy controls.
- « Previous
- 1
- 2
- 3
- Next »